1: Home (ALT-H)
2: HMA Joint (ALT-M)
3: Human Medicines (ALT-U)
- 3.1: Heads of Agencies (ALT-E)
- 3.2: CMDh (ALT-C)
- 3.3: MRI Product Index (ALT-R)
- 3.4: Directory (ALT-I)
4: Veterinary Medicines (ALT-V)

You are here: Human Medicines > CMDh > CMDh-Referrals

3.2.1: About CMDh (ALT-O)
3.2.2: Statistics (ALT-S)
3.2.3: Press Releases (ALT-P)
3.2.4: Procedural Guidance (ALT-L)
3.2.5: CMDh-Referrals
3.2.6: Product Information (ALT-T)
3.2.7: Advice from CMDh
3.2.8: Templates
3.2.9: CMD Working Parties / Working Groups (ALT-W)
3.2.10: Paediatric Regulation (ALT-G)
3.2.11: Pharmacovigilance (ALT-N)
3.2.12: Questions & Answers (ALT-Q)
3.2.13: Contact Form
3.2.14: Contact Points
3.2.15: What's new history (ALT-Y)

CMDh-Referrals

In order to view some of the documents on this website you need Acrobat Reader
(click here to download)

Overview of timetables 2013 (September 2012)

CMDh Standard Operating Procedure - Disagreement in procedures referred to CMDh (incl. Annex: Guidance on OE to CMDh) (September 2011) [Track version]

Guidance on oral explanations to CMDh - Annex to CMDh SOP on Disagreement in Procedures, Referral to CMDh (March 2010)

Information on applications referred to the CMDh in accordance with Article 29(1) of Directive 2001/83/EC and Article 13 of Regulation (EC) No 1234/2008

Tracking table (May 2013)

Questions and Answers on CMDh Referrals

Questions and Answers